Some immunotherapy treatments can cause immune cell associated neurotoxicity syndrome (ICANS). Find out more about it and the treatment you might have.

Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) is a common and potentially severe complication of CD19 CAR-T therapy. While some clinical risk factors have been described, the ...

Medical researchers in Japan have identified specific proteins associated with damaging immune responses that can affect the central nervous system after immunotherapy (1 Trusted Source Cerebrospinal ...

Cancer immunotherapies harness components of the immune system to induce long-term cancer remission. Immunotherapeutic agents include immune-checkpoint inhibitors (ICIs), bispecific T cell engagers ...

SPEAKER: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual ...